Immature neutrophils bring anti-PD-1 therapy in NASH-HCC to maturity

Gut. 2022 Apr 27:gutjnl-2022-327396. doi: 10.1136/gutjnl-2022-327396. Online ahead of print.

Authors

Michael Dudek¹, Frank Tacke²

Affiliations

¹ Institute of Molecular Immunology & Experimental Oncology, Technical University of Munich Hospital Rechts der Isar, Munchen, Germany.
² Department of Hepatology and Gastroenterology, Charité - Universitätsmedizin Berlin, Berlin, Germany frank.tacke@charite.de.

PMID: 35477865
DOI: 10.1136/gutjnl-2022-327396

No abstract available

Keywords: HEPATOCELLULAR CARCINOMA; IMMUNOTHERAPY; NONALCOHOLIC STEATOHEPATITIS.